Avacta Group Share News (AVCT)

Avacta Group Information

Buy AVCT Shares
Add AVCT to Watchlist
Add AVCT to Alert

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 40.25

Bid: 40.00

Ask: 40.50

Change: 0.25 (0.63%)

Spread: 0.50 (1.25%)

Open: 40.00

High: 40.50

Low: 39.75

Prev. Close: 40.00

Last checked at -

UK earnings, trading statements calendar - next 7 days

Thu, 21st Sep 2023 15:48

Friday 22 September
Ascential PLC	Half Year Results
Ergomed PLC	Half Year Results
First Tin PLC	Half Year Results
t42 IoT Tracking Solutions PLC	Half Year Results
t42 IoT Tracking Solutions PLC	Trading Statement
Monday 25 September
Alphawave IP Group PLC	Half Year Results
Devolver Digital Inc	Half Year Results
Dialight PLC	Half Year Results
Getech Group PLC	Half Year Results
Ondine Biomedical Inc	Half Year Results
Real Estate Investors PLC	Half Year Results
SpaceandPeople PLC	Half Year Results
Spectra Systems Corp	Half Year Results
Transense Technologies PLC	Full Year Results
Venture Life Group PLC	Half Year Results
Wilmington PLC	Full Year Results
Tuesday 26 September
Alliance Pharma PLC	Half Year Results
AG Barr PLC	Half Year Results
Animalcare Group PLC	Half Year Results
Asos PLC	Trading Statement
Boku Inc	Half Year Results
Card Factory PLC	Half Year Results
Cambridge Cognition Holdings PLC	Half Year Results
Close Brothers Group PLC	Full Year Results
Diaceutics PLC	Half Year Results
DigitalBox PLC	Half Year Results
Dillistone Group PLC	Half Year Results
EKF Diagnostics Holdings PLC	Half Year Results
Ferguson PLC	Full Year Results
Finsbury Food Group PLC	Full Year Results
IQGeo Group PLC	Half Year Results
Learning Technologies Group PLC	Half Year Results
LifeSafe Holdings PLC	Half Year Results
Mission Group PLC	Half Year Results
Mortgage Advice Bureau Holdings PLC	Half Year Results
NAHL Group PLC	Half Year Results
Next 15 Group PLC	Half Year Results
Newmark Security PLC	Full Year Results
NIOX Group PLC	Half Year Results
Origin Enterprises PLC	Full Year Results
PZ Cussons PLC	Full Year Results
Safestay PLC	Half Year Results
Smiths Group PLC	Full Year Results
Time Finance PLC	Full Year Results
tinyBuild Inc	Half Year Results
Wentworth Resources PLC	Half Year Results
Yu Group PLC	Half Year Results
Wednesday 27 September
Amicorp FS (UK) PLC	Half Year Results
Aquila European Renewables PLC	Half Year Results
Arix Bioscience PLC	Half Year Results
Avingtrans PLC	Full Year Results
Bens Creek Group PLC	Full Year Results
Biome Technologies PLC	Half Year Results
BioPharma Credit PLC	Half Year Results
Chapel Down Group PLC	Half Year Results
Everyman Media Group PLC	Half Year Results
Fadel Partners Inc	Half Year Results
NCC Group PLC	Full Year Results
Old Mutual Ltd	Half Year Results
Pantheon Infrastructure PLC	Half Year Results
Pendragon PLC	Full Year Results
Plant Health Care PLC	Half Year Results
Safestyle UK PLC	Half Year Results
Saga PLC	Half Year Results
Skillcast Group PLC	Half Year Results
Surface Transforms PLC	Half Year Results
Xeros Technology Group PLC	Half Year Results
Zinc Media Group PLC	Half Year Results
Thursday 28 September
Atlantic Lithium Ltd	Full Year Results
Avacta Group PLC	Half Year Results
Avation PLC	Full Year Results
Celadon Pharmaceuticals PLC	Half Year Results
Ceres Power Holdings PLC	Half Year Results
Dar Global PLC	Half Year Results
eEnergy Group PLC	Full Year Results
HSS Hire Group PLC	Half Year Results
Microlise Group PLC	Full Year Results
Novacyt SA	Half Year Results
Phoenix Spree Deutschland Ltd	Half Year Results
RBG Holdings PLC	Half Year Results
Shield Therapeutics PLC	Half Year Results
Silver Bullet Data Services Group PLC	Half Year Results
Trellus Health PLC	Half Year Results
Trinity Exploration & Production PLC	Half Year Results
XLMedia PLC	Half Year Results

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News

29 Jul 2020 13:46

Avacta expands partnership with Daewoong to Covid-19 therapy

(Sharecast News) - Biotherapeutics and reagents developer Avacta Group announced an expansion of its collaboration and license agreement with Daewoong Pharmaceutical and AffyXell Therapeutics - the joint venture established in South Korea by the two companies - to develop stem cell treatments on Wednesday.

22 Jul 2020 17:57

UK TRADING UPDATE SUMMARY: Virus Hits Mears But Tristel Gets Boost

22 Jul 2020 16:13

Avacta's Covid test collaboration with Adeptrix accepted into CONDOR

(Sharecast News) - Avacta Group has started work with the UK government's 'CONDOR' programme, it announced on Wednesday, to evaluate and clinically validate the high throughput Covid-19 bead-assisted mass spectrometry laboratory assay, developed with Adeptrix.

13 Jul 2020 11:23

Avacta Partners With Integumen To Detect Covid-19 In Waste Water

13 Jul 2020 09:18

Avacta signs Covid sewage test deal with Integumen

(Sharecast News) - Biotherapeutics company Avacta Group has entered into a collaboration with its AIM peer Integumen, it announced on Monday, to evaluate recently-generated Affimer reagents that bind the SARS-CoV-2 spike protein for the detection of the coronavirus in wastewater, to provide a real-time alert system to warn of localised Covid-19 outbreaks.

24 Jun 2020 13:55

IN BRIEF: Avacta Posts Positive Results For Covid-19 Detection Test

24 Jun 2020 08:36

Avacta upbeat on evaluation of Covid-19 test strips

(Sharecast News) - Avacta Group announced on Wednesday that the first 'Affimer'-based rapid test strips to detect SARS-CoV-2 (Covid-19) spike protein had been developed and evaluated by its partners at Cytiva - formerly GE Healthcare Life Sciences - and reportedly showed positive initial performance data.

22 Jun 2020 08:52

'No-swab' saliva test for coronavirus piloted in Britain

LONDON, June 22 (Reuters) - A weekly coronavirus testing regime using a "no-swab" saliva test is being trialled in Southampton, southern England, and could result in a simpler and quicker way to detect outbreaks of the virus, the British governme...

18 Jun 2020 11:55

Avacta reports promising findings on potential Covid therapy

(Sharecast News) - Avacta Group announced on Thursday that collaborative work with the Centre for Virus Research at the University of Glasgow has shown that its 'Affimer' reagents, which bind to the SARS-COV-2 (Covid-19) virus spike protein, prevent infection of human cells by a SARS-COV-2 model virus, and therefore provide a potential therapy for Covid-19 infection.

15 Jun 2020 15:52

UK Shareholder Meetings Calendar - Next 7 Days

9 Jun 2020 11:14

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test

9 Jun 2020 09:30

Avacta's Covid-19 test reaches prototype stage

(Sharecast News) - Avacta said its Covid-19 antigen test had reached prototype stage and could detect the virus in model samples.

4 Jun 2020 14:31

Avacta To Raise GBP48 Million To Accelerate Development Of Therapies

4 Jun 2020 09:27

Avacta raising £45m to fund diagnostics and therapies pipeline

(Sharecast News) - Biotherapeutic and reagent developer Avacta Group announced its intention to raise up to £45m through a placing to institutional and other investors, a direct subscription with the company, and offers to retail and other investors via the PrimaryBid platform, it announced on Thursday.

20 May 2020 10:16

Avacta signs Covid-19 test distribution deal with Boohoo founders

(Sharecast News) - Avacta Group has entered into an exclusive distribution agreement with Medusa19 for direct-to-consumer sales of a saliva-based rapid test for the Covid-19 antigen, it announced on Wednesday.

Latest Share Chat

Avacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Login to your account

Quickpicks are a member only feature

Login to your account